A detailed history of Centre Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Centre Asset Management, LLC holds 432,914 shares of PFE stock, worth $10.8 Million. This represents 2.7% of its overall portfolio holdings.

Number of Shares
432,914
Holding current value
$10.8 Million
% of portfolio
2.7%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $12 Million - $13.6 Million
432,914 New
432,914 $12.5 Million
Q2 2023

Jul 06, 2023

BUY
$36.12 - $41.79 $60,753 - $70,290
1,682 Added 2.63%
65,718 $2.41 Million
Q1 2023

Apr 03, 2023

BUY
$39.39 - $51.28 $39,547 - $51,485
1,004 Added 1.59%
64,036 $2.61 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $78,949 - $103,059
1,891 Added 3.09%
63,032 $3.23 Million
Q3 2022

Oct 04, 2022

SELL
$43.76 - $53.42 $1,400 - $1,709
-32 Reduced 0.05%
61,141 $2.68 Million
Q2 2022

Jul 06, 2022

BUY
$46.53 - $55.17 $2.85 Million - $3.37 Million
61,173 New
61,173 $3.21 Million
Q4 2019

Jan 14, 2020

SELL
$32.92 - $37.36 $13.1 Million - $14.9 Million
-398,163 Closed
0 $0
Q3 2019

Oct 21, 2019

BUY
$32.49 - $42.13 $6.58 Million - $8.54 Million
202,620 Added 103.62%
398,163 $14.3 Million
Q2 2019

Jul 15, 2019

BUY
$36.98 - $41.52 $475,673 - $534,071
12,863 Added 7.04%
195,543 $8.47 Million
Q1 2019

Apr 17, 2019

BUY
$37.5 - $41.2 $233,250 - $256,264
6,220 Added 3.52%
182,680 $7.76 Million
Q4 2018

Jan 14, 2019

BUY
$38.47 - $43.86 $6.79 Million - $7.74 Million
176,460 New
176,460 $7.31 Million
Q3 2018

Oct 03, 2018

SELL
$34.47 - $41.81 $7.34 Million - $8.91 Million
-213,070 Closed
0 $0
Q2 2018

Aug 06, 2018

BUY
$32.98 - $35.16 $7.03 Million - $7.49 Million
213,070 New
213,070 $7.73 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Centre Asset Management, LLC Portfolio

Follow Centre Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centre Asset Management, LLC with notifications on news.